No. | Age (years)/ Gender | The interval between onset of symptoms and diagnosis | CDI | Sites of involvement | Follow-up | Therapy | |
---|---|---|---|---|---|---|---|
(months) | At presentation | Follow-up | |||||
1 | 9 / Female | 108 | Present | PS | None | Alive, 39 ms | RT + HRT |
2 | 47 / Female | 1 | Present | PS | PS | Alive, 5 ms | HRT |
3 | 12 / Female | 36 | Present | PS + H | PS + H | Alive, 5 ms | HRT |
4 | 22 / Male | 2 | Present | PS + P | NA | NA | NA |
5 | 13 / Male | 4 | Present | PS + H | None | Alive, 41 ms | RT + HRT |
6 | 15 / Male | 1 | Present | PS + P | PS + P | Alive, 2 ms | HRT |
7 | 35 / Female | 18 | Present | PS | Liver involvement suspected | Died, 74 ms | RT + Surgery + HRT |